Liva Healthcare secures €24.5m funding led by Verlinvest

Copenhagen and London-based health tech company Liva Healthcare has secured a funding round of €24.5 million, led by Verlinvest.

The current fundraise comes in two tranches and brings the total amount raised by the company to €32 million. The company stated it will probably raise a Series C next year.

Liva says it aims to help people at risk of, or living with, chronic conditions such as Type 2 diabetes, obesity, and heart diseases by encouraging behavioural change. The company was founded in 2015 by the team behind independent health information portal, which was founded in 1998.

Liva’s clients include Amgen, AXA Health, City of Copenhagen, Bupa Australia and several other players in public healthcare, insurance and life science industries globally. The company is also a partner to NHS England on its National Diabetes Prevention Programme. Liva operates in the UK, Australia, Ireland, the Netherlands, Belgium, Denmark, Sweden, and Finland with operations currently being setup in Germany and Switzerland.

André Sode, chief executive of Liva Healthcare, said: “This new funding, from one of Europe’s strongest purpose-led, consumer growth investors, will substantially accelerate our expansion in core European markets. Covid-19 has demonstrated how effective remote digital health solutions can be. With healthcare providers around the world looking for scalable solutions to combat the rise in diabetes and obesity, we are ideally placed to support and have experienced a significant increase in interest as a result.” 

Simone Sallustio, executive director at Verlinvest, added: “This investment represents a major new entry into digital health for Verlinvest, where technology is fuelling consumer revolutions. Digital healthcare has been vital in getting treatment to patients during the pandemic and this trend will continue as effective virtual programmes give people more flexible healthcare options. Liva’s advanced technology and proven clinical outcomes sets it apart from its competitors. In this exciting and rapidly evolving space, Liva’s experience and established partnerships represent a strategic choice for Verlinvest.” 

Rune Bech, co-founder and chairman of Liva Healthcare and co-founder of NetDoctor, said: “This is a major leap for us. Verlinvest will help us to accelerate our ambitious growth plans. The existing investment partners are also contributing to this funding round and look forward to welcoming Verlinvest onboard. Verlinvest has an impressive track record of enabling successful consumer brands to grow rapidly across geographies and channels. VerlInvest has, time and again, shown its excellent instinct for partnering with visionary, mission-driven entrepreneurs who drive consumer revolutions – as in the case of Oatly, leader in the global plant-based food movement.” 

Date published: January 6, 2021

Subscriber content

To get unlimited access subscribe today


Already a subscriber? Login